Metraipolis › archive › dc_53173ed69d2d

Effectiveness comparison of nirmatrelvir/ritonavir versus molnupiravir in COVID-19 patients with comorbidities in Taiwan: a multi-centre electronic health… — Europe PMC PMID:41382264

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41382264
DOI
10.1186/s12879-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-10-10T01:01:16.400Z
SHA-256 of the archived text
d9b792eee1bc1ba017151652fc830b24b4468f2fc2cb6f603a7df2d24ad32a16
Stable URL of this page
https://metraipolis.com/documento/dc_53173ed69d2d

How to cite

Effectiveness comparison of nirmatrelvir/ritonavir versus molnupiravir in COVID-19 patients with comorbidities in Taiwan: a multi-centre electronic health… — Europe PMC PMID:41382264 — Europe PMC (en), https://europepmc.org/article/MED/41382264 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_53173ed69d2d (Metraipolis archive dc_53173ed69d2d, sha256 d9b792eee1bc1ba017151652fc830b24b4468f2fc2cb6f603a7df2d24ad32a16)
BibTeX
@misc{dc53173ed69d2d,
  title = {Effectiveness comparison of nirmatrelvir/ritonavir versus molnupiravir in COVID-19 patients with comorbidities in Taiwan: a multi-centre electronic health… — Europe PMC PMID:41382264},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41382264},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_53173ed69d2d; sha256 d9b792eee1bc1ba017151652fc830b24b4468f2fc2cb6f603a7df2d24ad32a16},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41382264. Agents can read the archived copy with the MCP tool read_document.